Vaccines for tumor prevention: a pipe dream?
Whether or not a tumor expresses peculiar antigens that differentiate it from normal cells was intensively investigated in the 1950s. A conclusive answer was provided in 1960 when George Klein showed that a tumor can be rejected by the immune response elicited by a vaccine administered to the same m...
Saved in:
| Main Author: | Guido Forni |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
The Journal of Infection in Developing Countries
2015-07-01
|
| Series: | Journal of Infection in Developing Countries |
| Subjects: | |
| Online Access: | https://jidc.org/index.php/journal/article/view/7201 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Biomaterials nanoplatform-based tumor vaccines for immunotherapy
by: Zhilin Li, et al.
Published: (2025-09-01) -
Targeting Antigen‐Presenting Cells to Enhance the Tumor‐Spleen Immunity Cycle through Liposome‐Neoantigen Vaccine
by: Yu Xu, et al.
Published: (2025-05-01) -
A pH-responsive PROTAC-based nanosystem triggers tumor-specific ferroptosis to construct in situ tumor vaccines
by: Linghong Huang, et al.
Published: (2025-04-01) -
Cancer Vaccines: A Promising Therapeutic Strategy in Advanced Solid Tumors
by: Simona Caridi, et al.
Published: (2025-05-01) -
Challenges and New Directions in Therapeutic Cancer Vaccine Development
by: Danjie Pan, et al.
Published: (2024-11-01)